Fluoxetine vs placebo for depressive symptoms after stroke: Failed randomised controlled trial

International Journal of Geriatric Psychiatry

Volumn 22, Issue 10, 2007, Pages 963-965

  Ruddell, M ^a   Spencer, A ^a   Hill, K ^a   House, A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Antidepressant prescribing; Depression; Medication review; Primary care; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELDERLY CARE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT REFUSAL;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; PLACEBOS; RESEARCH; RETROSPECTIVE STUDIES; STROKE;

EID: 35448938089     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1771     Document Type: Article

References (6)

1. Eriksson M, Asplund K, Glacier E, et al. for The Risk-Stroke Collaboration. 2004. Self-reported depression and use of anti-depressants after stroke: a national survey. Stroke 35: 936-941.
2. Goldberg DP, Hillier VF. 1979. A scaled version of the General Health Questionnaire. Psychologic Med 9: 139-145.
3. Hackett ML, Anderson CS, House AO. 2004. Interventions for treating depression after stroke (Cochrane Review). In The Cochrane Library, Issue 3, 2004. John Wiley & Sons, Ltd: Chichester.
4. Middleton N, Gunnell D, Whitley E, et al. 2001. Secular trends in antidepressant prescribing in the UK 1975-1998. J Public Health Med 23(4): 262-266.
5. Royal College of Physicans. 2004. National Clinical Guidelines for Stroke, 2nd edn. Royal College of Physicians: London.
6. Petty D, House A, Knapp P, et al. 2006. Prevalence, duration and indications for prescribing antidepressants in primary care. Age Ageing 35(5): 523-526.